Pliant Therapeutics, Inc. - PLRX Net earnings per one share for the last twelve months

Pliant Therapeutics Inc (PLRX) - corporate logo

This price trend reflects the EPS TTM dynamics for Pliant Therapeutics (PLRX), which currently stands at 49.10. Pliant Therapeutics (PLRX) generates revenue by developing small molecules to combat organ fibrosis, focusing on insurance reimbursements. High R&D costs and patent protection create significant barriers to entry for competitors under strict FDA oversight. Liquidity supports financial stability, although business success depends on the results of final drug trials.

PLRX: Pliant Therapeutics, Inc. Net earnings per share for the last 12 months 02/11/2024 - 11/17/2026

Pliant Therapeutics, Inc. - analytical breakdowns and key metrics (PLRX)

- issuer market value details:
Fundamental company valuation:PLRX - Pliant Rx
Brand item of pliantrx.com

Strategic alliances formed by Pliant Therapeutics (PLRX) in the fight against fibrosis determine the company's financial stability through capital inflows from pharma behemoths. By analyzing the YoY TTM net income growth per share, an investor can observe the percentage change in EPS over the last four quarters, allowing for an assessment of molecule commercialization efficiency and a balancing of the risk of overpaying for assets relative to profit potential.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|ABEO: Earnings per share for the trailing year|Earnings per share for the last twelve months Mereo BioPharma Group (MREO)|Net earnings per share (EPS TTM) protalix.com (PLX)|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)